Prostataspezifische Membranantigen-Positronenemissionstomographie (PSMA-PET) für Urologen – wann und welcher Tracer?

BACKGROUND: Prostate-specific membrane antigen positron emission tomography (PSMA PET) is increasingly replacing conventional imaging for staging of prostate cancer. A major challenge is its appropriate use and correct interpretation.

OBJECTIVES: How and when is PSMA PET used in patient care to optimally direct therapy?

MATERIALS AND METHODS: Systematic presentation and discussion of the current state of knowledge, guidelines and expert knowledge on PSMA PET with a summary of ongoing studies.

CONCLUSION: PSMA PET is the new standard for systemic staging of prostate cancer, enabling precision patient care with novel local, oligometastatic, and systemic treatment approaches.